http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g#Head
http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g#assertion
http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g#provenance
http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g#pubinfo
http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g#assertion
http://purl.obolibrary.org/obo/DOID_2349
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_2349
http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB01576
http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g#association
http://www.w3.org/2000/01/rdf-schema#label
"Advanced arteriosclerosis, symptomatic cardiovascular disease, moderate to severe hypertension, hyperthyroidism, known hypersensitivity or idiosyncrasy to the sympathomimetic amines, glaucoma. Agitated states. Patients with a history of drug abuse. Known hypersensitivity or idiosyncrasy to amphetamine. In patients known to be hypersensitive to amphetamine, or other components of dextroamphetamine sulfate extended-release capsules. Hypersensitivity reactions such as angioedema and anaphylactic reactions have been reported in patients treated with other amphetamine products ( see ADVERSE REACTIONS Patients taking monoamine oxidase inhibitors (MAOIs), or within 14 days of stopping MAOIs (including MAOIs such as linezolid or intravenous methylene blue), because of an increased risk of hypertensive crisis ( see WARNINGS and Drug Interactions"
http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g#association
https://w3id.org/biolink/vocab/relation
https://schema.org/MedicalContraindication
https://identifiers.org/drugbank:DB01576
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g#provenance
http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g#pubinfo
http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g#sig
http://purl.org/nanopub/x/hasSignature
MLliaJTAG4ksx1usYvm8Qaf8IoyDdJLlvzE4stw4O2+i+dgQr3EdRSf9Qg7pstn3DPpZ4SyCJftKeshwXlOeh2kiUg73MgFIL7aAPSUWfxJyNHydj+eFoKbvEwSjSUDcMypqAwk45tB/QVGJ6sFU37ua0+e0P+hZ4EKAC9/LfUI=
http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g
http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g
http://purl.org/dc/terms/created
2021-08-23T12:59:08.984+02:00
http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAeNEGDQZNwgwKHdeGztMfOSsgFrbMhxmLxEA5R0rtE_g
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY